MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 563546 | Name: TG-46

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TG-46 is an inhibitor of JAK2, FLT3, RET, JAK3.

Chemical Structure

TG-46
CAS#936091-15-5

Theoretical Analysis

MedKoo Cat#: 563546

Name: TG-46

CAS#: 936091-15-5

Chemical Formula: C26H34N6O3S

Exact Mass: 510.2413

Molecular Weight: 510.65

Elemental Analysis: C, 61.15; H, 6.71; N, 16.46; O, 9.40; S, 6.28

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
TG-46; TG 46; TG46;
IUPAC/Chemical Name
N-tert-Butyl-3-[[5-methyl-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
InChi Key
MMXZBJJTHQWMEN-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H34N6O3S/c1-19-17-27-25(29-21-10-8-20(9-11-21)18-32-12-14-35-15-13-32)30-24(19)28-22-6-5-7-23(16-22)36(33,34)31-26(2,3)4/h5-11,16-17,31H,12-15,18H2,1-4H3,(H2,27,28,29,30)
SMILES Code
O=S(C1=CC=CC(NC2=NC(NC3=CC=C(CN4CCOCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 510.65 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kim EY, Lee JW, Lee MY, Kim SH, Mok HJ, Ha K, Ahn YM, Kim KP. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients. Psychiatry Res. 2018 Jul;265:174-182. doi: 10.1016/j.psychres.2018.04.029. Epub 2018 Apr 25. PubMed PMID: 29719272. 2: Belkoff L, Brock G, Carrara D, Neijber A, Ando M, Mitchel J. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12801. Epub 2017 Mar 10. PubMed PMID: 28295450. 3: Al Faris NA, Al Othman ZA, Ahmad D. Effects of Mesembrrybryanthemum forsskalei Hochst seeds in lowering glucose/lipid profile in streptozotocin-induced diabetic rats. J Food Sci Technol. 2011 Oct;48(5):616-21. doi: 10.1007/s13197-010-0152-8. Epub 2010 Nov 5. PubMed PMID: 23572796; PubMed Central PMCID: PMC3551122. 4: Quraishi SA, Schuler GH, Janicki PK. 5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities. J Clin Anesth. 2011 Jun;23(4):297-302. doi: 10.1016/j.jclinane.2010.11.003. PubMed PMID: 21663814. 5: Kipnes MS, Roth EM, Rhyne JM, Setze CM, Lele A, Kelly MT, Sleep DJ, Stolzenbach JC. Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study. Clin Drug Investig. 2010;30(1):51-61. doi: 10.2165/11319800-000000000-00000. PubMed PMID: 19995098. 6: Fregolente PB, Pinto GM, Wolf-Maciel MR, Filho RM. Monoglyceride and diglyceride production through lipase-catalyzed glycerolysis and molecular distillation. Appl Biochem Biotechnol. 2010 Apr;160(7):1879-87. doi: 10.1007/s12010-009-8822-6. Epub 2009 Oct 28. PubMed PMID: 19862491. 7: Oury C, Daenens K, Hu H, Toth-Zsamboki E, Bryckaert M, Hoylaerts MF. ERK2 activation in arteriolar and venular murine thrombosis: platelet receptor GPIb vs. P2X. J Thromb Haemost. 2006 Feb;4(2):443-52. PubMed PMID: 16420578. 8: Bove CM, Yang Z, Gilson WD, Epstein FH, French BA, Berr SS, Bishop SP, Matsubara H, Carey RM, Kramer CM. Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling. Hypertension. 2004 Mar;43(3):680-5. Epub 2004 Jan 19. PubMed PMID: 14732725. 9: Sheikh-Bagheri D, Rogers DW. Sensitivity of megavoltage photon beam Monte Carlo simulations to electron beam and other parameters. Med Phys. 2002 Mar;29(3):379-90. PubMed PMID: 11930913. 10: Rong N, Ausman LM, Nicolosi RJ. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids. 1997 Mar;32(3):303-9. PubMed PMID: 9076667. 11: Imamura H, Tanaka K, Hirae C, Futagami T, Yoshimura Y, Uchida K, Tanaka A, Kobata D. Relationship of cigarette smoking to blood pressure and serum lipids and lipoproteins in men. Clin Exp Pharmacol Physiol. 1996 May;23(5):397-402. PubMed PMID: 8713678. 12: Rastogi SK, Gupta BN, Husain T, Mathur N. Cardio-respiratory studies on glass bangle workers. Int Arch Occup Environ Health. 1989;61(7):487-93. PubMed PMID: 2777393. 13: Taskinen MR, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes. 1986 Nov;35(11):1268-77. PubMed PMID: 3530855.

View History

AG1295

AG1295

Featured